- Apple’s new smartwatch alert missed over half of hypertension cases in a clinical study. (Statnews)
- The FDA sent 75 cease and desist letters to drug companies over misleading TV ads.
- Arnold Kling on AI.
- When generics are included, Medicare and Medicaid pay on average 18 percent less per prescription than public programs in five other countries.
- There are 400 million people in the world with rare genetic diseases. Gene therapy might help them, but it’s too expensive. (NYT)
- Trump’s $100,000 tax on H1-B visas is a disproportionately unfair tax on small businesses and does not solve any real problem.
Category: Artificial Intelligence and Healthcare
Friday Links
- Silicon Valley elite are spending up to $50,000 on genetic tests that claim to predict IQ alongside disease risks in their offspring.
- Over the past ten years, biosimilars have saved the U.S. health care system north of $56 billion, with the potential to save an additional $181 billion in the next five years.
- Study: existing AI platforms could deliver up to $360 billion in annual cost reductions without harming the quality of care delivered to patients.
- An argument: AI will kill us all.
An AI Doctor Will See You Now… (right on your computer screen)
A while back my wife saw her doctor for an ongoing health concern. Years later we still wonder why an obvious diagnosis was missed and what could have been done to avoid unnecessary care. Why do I say the diagnosis was obvious? I recently entered a one-sentence description of the problem into Google, and it told me the exact cause and listed a variety of websites discussing treatments.
Thursday Links
- Is US government debt becoming a serious problem?
- More on bond prices.
- Chinese innovation: China employs roughly 2.6 million full-time equivalent (FTE) researchers versus about 1.7 million in the United States.
- CTUP: Biden made the poor poorer and Trump made everyone richer
- How AI is affecting the job market.